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Brazil 
1. Introduction 
Loxosceles is the most poisonous spider in Brazil and, at least, three different species of 
medical importance are known in Brazil (L. intermedia, L. gaucho, L. laeta), with more than 
5000 cases of envenomation reported each year. In South Africa, L. parrami and L. spinulosa 
are responsible for cutaneous loxoscelism (Newlands et al., 1982). In Australia, a 
cosmopolitan species, L. rufescens, is capable of causing ulceration in humans. In the USA, at 
least five Loxosceles species, including L. reclusa (brown recluse), L. apachea, L. arizonica, L. 
unicolor and L. deserta are known to cause numerous incidents (Ginsburg &Weinberg, 1988; 
Gendron, 1990; Bey et al., 1997; Desai et al., 2000). 
Several studies have indicated that sphingomyelinase D (SMase D) present in the venoms of 
Loxosceles spiders is the main component responsible for the local and systemic effects 
observed in loxoscelism (Forrester et al., 1978; Kurpiewski et al., 1981; Tambourgi et al., 
1998, 2000, 2002, 2004, 2005, 2007; van den Berg et al., 2002, 2007; Fernandes Pedrosa et al., 
2002; Paixão Cavalcanti et al., 2006, Tambourgi et al., 2010). SMases D hydrolyze 
sphingomyelin resulting in the formation of ceramide-1-phosphate and choline (Forrester et 
al., 1978; Kurpiewski et al., 1981; Tambourgi et al., 1998) and, in the presence of Mg2+, are 
able to catalyze the release of choline from lysophosphatidylcholine (van Meeteren et al., 
2004). 
All spider venom SMases D sequenced to date display a significant level of sequence 
similarity and thus likely possess the same (ǂ/ǃ)8 or TIM barrel fold (Murakami et al., 2005, 
2006). Based on sequence identity, biochemical activity and molecular modelling, a scheme 
for classification of spider venom SMases D was proposed (Murakami et al., 2006). The  
class 1 enzymes include SMase I and H13, SMases D from L. laeta, which possess a single 
disulphide bridge and contain an extended hydrophobic loop or variable loop (Murakami et 
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al., 2006). All other SMases D, such as SMases  P1 and P2 from L. intermedia (Tambourgi et 
al., 1998, 2004), Lr1 and Lr2 from L. reclusa and Lb1, Lb2 and Lb3 from L. boneti (Ramos-
Cerrillo et al., 2004) belong to class 2, which contains an additional intra-chain disulphide 
bridge that links the flexible loop with the catalytic loop (Murakami et al., 2006). The class 2 
enzymes can be further subdivided into class 2a and class 2b depending on whether they are 
capable of hydrolysing sphingomyelin or not, respectively (Murakami et al., 2006). One 
representative of class 2b is the isoform 3 from L. boneti an inactive SMase D isoform 
(Ramos-Cerrillo et al., 2004) (Table 1). 
Studies on the effect of venoms from synanthropic species of Loxosceles spiders have been 
reported, however, analysis from those living in natural environment have been poorly 
performed. Loxosceles species are present in several different habitats, including the 
karstic environment, and in Brazil it is the most common troglophile arachnid. The 
spiders are commonly found on the walls at the entrance of caves, especially in the shady 
rocky areas. 
In order to characterize the venom of Loxosceles species living in natural environment, and 
compare their venom to those of synanthropic species, we have explored the caves of 
‘Parque Estadual do Alto do Ribeira’ (PETAR - Ribeira Valley, SP, Brazil), which is an area 
of importance to both tourism and scientific research, due to the combination of tropical 
forest and extensive cave systems. Spiders captured in the caves of PETAR were identified 
by morphological analysis as Loxosceles adelaida Gertsch (1967), which belongs to ‘gaucho 
group’ (Gertsch, 1967). This group includes four species: L. adelaida, L. gaucho, L. similis and 
L. variegata. L. gaucho belongs to the synanthropic fauna of Brazilian arachnids and is 
considered an important cause of the loxoscelic accidents in the south–eastern region of the 
country. Thus, the aims of the present study were to clone and express SMases D from the 
spider gland of L. adelaida, captured in the caves of PETAR (Brazil), to compare the 
functional activities of the recombinant proteins with toxins from synanthropic species and 
to investigate the inter- and intra-species cross-reactivities of antibodies raised against the 
purified recombinant proteins. 
 
SMase 
Class 
Loxosceles 
sp 
SMase D GenBank Reference 
I L. laeta 
SMase I 
H13 (SMase 
II) 
AY093599.1 
AY093600.1 
Fernades-Pedrosa et al., 2002; 
de Santi-Ferrata et al., 2009  
Fernandes-Pedrosa et al., 
2002 
II 
L. intermedia 
P1 
P2 
AY304471.2 
AY304472.2 
Tambourgi  et al., 2004 
Tambourgi et al., 2004 
L. reclusa 
Lr1 
Lr2 
AY559846.1 
AY559847.1 
Ramos-Cerrillo et al., 2004 
Ramos-Cerrillo et al., 2004 
L. boneti 
Lb1 
Lb2 
Lb3 
AY559844.1 
- 
AY559845.1 
Ramos-Cerrillo et al., 2004 
Ramos-Cerrillo et al., 2004 
Ramos-Cerrillo et al., 2004 
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2. Material and methods 
2.1 Chemicals, reagents and buffers 
Tween 20, bovine serum albumin (BSA), sphingomyelin (SM), choline oxidase, horseradish 
peroxidase (HRPO) and 3-(4-hydroxy-phenyl) propionic acid were purchased from Sigma 
Co. (St. Luis, MO). 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) and Nitroblue Tetrazolium 
(NBT) were from Promega Corp. (Madison, WI, USA). Goat anti-horse IgG-alkaline 
phosphatase (GAH/IgG-AP) was from Sigma Co. (St. Luis, MO). Horse serum against 
SMases D P1 and P2 from L. intermedia and SMase D I from L. laeta was obtained as 
previously described (De Almeida et al., 2008). Buffers were: Veronal-Buffered Saline 
(VBS2+), pH 7.4: 10 mM NaBarbitone, 0.15 mM CaCl2 and 0.5 mM MgCl2; Phosphate-
Buffered Saline (PBS), pH 7.2: 10 mM NaPhosphate, 150 mM NaCl; HEPES-Buffered saline 
(HBS), pH 7.4: 10 mM Hepes, 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2. 
2.2 Spiders and venoms  
Loxosceles intermedia, L. laeta, L. gaucho and L. adelaida spiders were provided by 
Immunochemistry Laboratory, Butantan Institute, Brazil (permission Nº 1/35/95/1561-2 
was provided by the Brazilian Institute of Environment and Renewable Natural Resources - 
IBAMA - a Brazilian Ministry of the Environment's enforcement agency). The venoms were 
obtained (permission Nº 01/2009/IBAMA) by electrostimulation by the method of Bucherl 
(1969) with slight modifications. Briefly, 15–20 V electrical stimuli were repeatedly applied 
to the spider sternum and the venom drops were collected with a micropipette in PBS, 
aliquoted and stored at -20°C. The protein content of the samples was evaluated using the 
BCA Protein Assay Kit (Pierce Biotechnology, MA, USA).  
2.3 Animals 
The adult New Zealand white rabbits weighing approximately 3 kg were supplied by 
Butantan Institute animal facilities, SP, Brazil. All the procedures involving animals were in 
accordance with the ethical principles in animal research adopted by the Brazilian College of 
Animal Experimentation. 
2.4 cDNA generation 
The venom glands were removed from 50 specimens of Loxosceles adelaida 5 days after 
venom extraction, when the maximum level of RNA synthesis was achieved. Then, the 
glands were quickly frozen in liquid nitrogen and stored at −80°C until used. The total RNA 
was extracted from the glands using the Trizol reagent, according to the manufacturer's 
instructions (Invitrogen, USA). The quality and yield of total RNA were verified by the 
integrity of 28S and 18S rRNA, through denaturing agarose gel electrophoresis, and 
spectrophotometrically using the ratio 260/280 nm. The cDNAs were synthesised from 5 µg 
of total RNA using the cDNA Cycle® Kit for RT-PCR (Invitrogen, USA). 
2.5 PCR Amplification of Sphingomyelinase D homologue from L. adelaida 
The SMase D cDNA was amplified by PCR using total reverse transcriptase-PCR products 
as template. Degenerate primers AdeF1 (5’-G(G/A)ACG(C/A)GC(G/T)GATAA(A/C) 
CGTCG(A/T)CC–3’) and AdeR2 (5’–CTA(A/T/G)TT(C/T)TT(A/G)AA(A/T/G) 
GTCTCCCA(A/T)GG–3’), were designed according to the highly conserved 5′- and 3′-  
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SMases D P1 and P2 from L. intermedia (accession numbers AY304471 and AY304472, 
respectively) and Smase D I from L. laeta (accession number AY093599) (Tambourgi et al, 
2004; Fernandes Pedrosa et al, 2002). The PCR protocol included denaturation at 96°C for 3 
min, followed by 35 cycles of denaturation (30 s at 95°C), annealing (30 s at 58°C), and 
extension (2 min at 72°C), and a final extension for 7 min at 72°C. The amplified fragments 
were purified by low melting using the UltraPure™ Low Melting Point Agarose (Invitrogen, 
USA) and cloned in a pGEM-T easy vector (Promega, USA). E. coli XL1-Blue competent cells 
(Strategene, USA) were transformed following the manufacturer's instructions. Positive 
clones were selected by growing the transformed cells in Luria broth (LB) medium 
containing 100 Ǎg/ml ampicilin and blue-white color screening. The nucleotide sequence 
was determined by the dideoxy chain-termination method using the BigDye™ Terminator 
Cycle Sequence Kit and the ABI 3100 automatic system (Applied Biosystems, USA). 
2.6 Subcloning in expression vector 
The cDNA corresponding to the mature L. adelaida SMase D was amplified from plasmids 
containing full length sequence using primer AdeF3 (5’-
CTCGAGGCGGATAAACGTCGACCCATATG-3’), which contains a XhoI restriction site 
(underlined) and AdeR4 (5'-CCATGGTCAATTCTTGAAAGTCTCC-3'), which includes a 
restriction site for NcoI (underlined) and a stop codon (in italics and bold).  
PCR fragments (approximately 900 bp) were digested with XhoI and NcoI and cloned into 
the corresponding sites in pRSET-B bacterial expression vector (Invitrogen, USA). The use of 
the pRSET-B bacterial expression system results in the expression of a recombinant fusion 
protein, including a 6xHis-tag at the N-terminus and a 26 amino acid linker followed by the 
mature protein (N-terminal amino acid sequence before the coding sequence of the mature 
protein: ‘MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPSSR’). 
2.7 Recombinant protein expression and purification 
Recombinant proteins were produced as described previously (Tambourgi et al., 2004). In 
brief: pRSETB-L. adelaida SMase D cDNA transformed Escherichia coli BL21 (DE3) 
(Invitrogen, USA) cells were inoculated in 500 mL of 2YT/amp and grown overnight at 37°C 
and induced with IPTG. Recombinant proteins were harvested from the pellet by french-
pressure and purified on a Ni (II) Chelating Sepharose Fast Flow column (Pharmacia, 
Sweden, 1.0×6.4 cm). The fractions containing the recombinant proteins were pooled and 
concentrated using Centricon-30 (30,000-mw cutoff; Amicon, Inc., USA). Smase D P1 from L. 
intermedia and SMase D I from L. laeta were obtained as previously described (Tambourgi et 
al., 2004; Fernandes-Pedrosa et al., 2002).;The protein content of the samples was evaluated 
by the BCA protein kit assay, following the manufacturer's protocol (Pierce, USA). 
2.8 Enzymatic activity  
The SMase D enzymatic activity was estimated by determining the choline liberated from 
lipid substrates, using a fluorimetric assay (Tokumura et al., 2002). Briefly, sphingomyelin 
(SM – 50 Ǎg) was diluted in 1 mL HEPES-buffered saline (HBS). Samples of the recombinant 
proteins or venom (2.5 to 20 Ǎg) was added and the reaction was developed for 20 min at 
37°C. After incubation, a mixture composed by 1 unit/mL choline oxidase, 0.06 unit/mL of 
horseradish peroxidase and 50 ǍM of 3-(4-hydroxy-phenyl) propionic acid in HBS was 
added and incubated for 10 min. The choline liberated was oxidized to betaine and H2O2 
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and this product determined by fluorimetry at ǌem=405 nm and ǌex=320 nm, using 96-well 
microtiter plates, in a spectrofluorimeter (Victor 3TM, Perkin-Elmer, USA). 
2.9 Electrophoresis and western blotting 
Samples of the recombinant SMases D (5 µg) or Loxosceles venoms (10 µg) were solubilised in 
non-reducing sample buffer, run on 12% SDS-PAGE (Laemmli, 1970) and silver stained. 
Alternatively, gels were blotted onto nitrocellulose (Towbin et al., 1979). After transfer, the 
membranes were blocked with PBS containing 5% BSA and incubated with horse serum anti-
SMases D from L. intermedia (Smases D P1 and P2) and L. laeta (SMase D I) (diluted 1:1000) for 
1 h at room temperature. Membranes were washed 3 times with PBS/0.05% Tween 20 for 5 
min each wash, and incubated with GAH/IgG-AP (1:7500) in PBS/1% BSA for 1 h at room 
temperature. After washing 3 times with PBS/0.05% Tween 20 for 5 min each wash, blots were 
developed using NBT/BCIP according to the manufacturer’s instructions (Promega). 
2.10 Normal human serum and erythrocytes 
Human blood was obtained from healthy donors. Blood samples drawn to obtain sera were 
collected without anticoagulant, allowed to clot for 4 h at 4ºC and the normal human serum 
(NHS) was stored at -80oC. Blood samples drawn to obtain erythrocytes for subsequent use 
as target cells were collected in anticoagulant (Alsever´s old solution: 114 mM citrate, 27 mM 
glucose, 72 mM NaCl, pH 6.1).  
2.11 Treatment of erythrocytes with Loxosceles recombinant proteins/venom 
Human erythrocytes were washed and resuspended at 1.5% in VBS2+ and incubated with 
different concentrations of the recombinant proteins or venom for 1 h at 37oC. Control 
samples were incubated with VBS2+. The cells were washed, resuspended to the original 
volume in VBS2+ and analysed in a haemolysis assay as described (Tambourgi et al., 2000). 
2.12 Dermonecrotic activity 
Samples of L. adelaida venom (5 µg), SMase P1 from L. intermedia (5 µg) or SMase D from L. 
adelaida (5 µg and 10 µg), in PBS, were injected intradermally in the shaved back of adult 
rabbits. Control sites were injected with equal volume of PBS. The size of the lesions was 
measured over a period of 16, 24, 48 and 72 h. After 72 h, the animals were euthanized and 
skin specimens were obtained for histological examination.  
2.13 Histological analysis  
Skin samples were fixed in 4% buffered formalin solution, and then embedded in paraffin. 
Tissue sections were stained with haematoxylin and eosin and examined for the presence of 
epithelial necrosis, epithelial slough, dermal infiltrates, haemorrhage and level of collagen 
dissociation in the dermis and skin muscle fiber degeneration.  
2.14 Homology molecular modelling and quality analysis 
The atomic coordinates of SMase I, a SMase D from L. laeta (PDB accession code: 1XX1) was 
used as 3D-model for restraint-based modelling as implemented in the program 
MODELLER (Fiser and Sali, 2003). The overall model was improved enforcing the proper 
stereochemistry using spatial restraints and CHARMM energy terms, followed by conjugate 
gradient simulation based on the variable target function method (Fiser and Sali, 2003). Ten 
models were built for the L. adelaida SMase D sequence based on the (m)GenThreader 
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alignment (Lobley et al., 2009) and the model with best global score was selected for explicit 
solvent MD simulations using the package Yasara (http://www.yasara.org) to check its 
stability and consistency.  The overall and local quality analyses of the final model were 
assessed by VERIFY3D (Eisenberg et al., 1997), PROSA (Wiederstein and Sippl, 2007) and 
VADAR (Willard et al., 2003). Three-dimensional structures were displayed, analyzed and 
compared using the program COOT (Emsley and Cowtan, 2004). 
2.15 Molecular dynamics simulation of the enzyme-substrate complex 
The SMase D I structure (PDBid 1XX1) obtained from the Protein Data Base (www.rcsb.org) 
and a predicted structure of the sphingomyelin (SM) was manually docked using the sulfate 
ion from the experimental structure, as a reference of the position of the phosphate moiety 
of the SM. 
The structure was prepared for energy minimization (EM) molecular dynamics (MD) 
simulation using YASARA program for building missing atoms and hydrogens in the 
model. The parameters for the force field were obtained from YAMBER3 (Krieger et al., 
2004). The pKa values for Asp, Glu, His and Lys residues were predicted. Based on the pH 
7.0, the protonation states were assigned according to convention: Asp and Glu were 
protonated if the predicted pKa was higher than the pH; His was protonated if the predicted 
pKa was higher than the pH and it did not accept a hydrogen bond, otherwise it was 
deprotonated; Cys was protonated; Lys was deprotonated if the predicted pKa was lower 
than the pH and; Tyr and Arg were not modified (www.yasara.org). A simulation box was 
defined at 15 Å around all atoms of each macromolecular complex. Then, the simulation box 
was filled with water molecules and Na/Cl counter ions, that were placed at the locations of 
the lowest/highest electrostatic potential, until the cell neutralization, and the requested 
NaCl concentration reached 0.9%. A short MD simulation was performed for the solvent 
adjust, and water molecules were subsequently deleted until the water density reached 
0.997 g/mL. A short steepest descent EM was carried until the maximum atom speed 
dropped below 2200 m/s. Then 500 steps of simulated annealing EM were performed with a 
target temperature at 0 K. Finally, a 20 ns MD production simulation was performed at 298 
K and a non-bonded cutoff of 7.86 A. A snapshot was saved every 7.5 ps (picoseconds). The 
graphical analysis was carried out using Visual Molecular Dynamics (VMD) software 
(Humphrey et al., 1996) and the plots were generated using R (cran.r-project.org). 
Ligand binding analysis was carried out taking into account the potential energy obtained 
with the current force field for the complex and components:  
Ebinding = (Eprotein + Eligant) - Ecomplex 
In our equation, the complex energy is placed after the energy of the components; therefore, 
higher energies equated to higher affinity between the protein and the substrate. 
3. Results 
3.1 Identification and characterization of L. adelaida recombinant protein 
Analysis of L. adelaida SMase D clone revealed that the mature cDNA covers an open reading 
frame of 843 nucleotides encoding 280 amino acid residues (GenBank JN202927). The complete 
nucleotide sequence of this cDNA clone and the deduced amino acid sequence are shown in 
Figure 1A. Sequence analysis revealed that SMase D from L. adelaida exhibits similarity with 
previously characterized class 2 SMase D and shares 75% and 59% homology with the 
sequences of L. intermedia SMase P1 and L. laeta SMase I, respectively (Figure 1B). 
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Fig. 1. Sequence of L. adelaida SMase D A1. [A] Complete cDNA sequence of L. adelaida 
SMase D A1 and its deduced mature protein sequence. The primers used in the subcloning 
are underlined. The nucleotide residues are numbered in the 5’ to 3’ direction. [B] 
Alignment of the complete deduced amino acid sequences of L. adelaida SMase D A1 and 
SMase D P1 of L. intermedia and SMase D I of L. laeta. The conserved residues forming the 
catalytic pocket are underlined and in bold letters. Open boxes indicate the two conserved 
cysteine residues in SMases D. The catalytic loops (residues 45-59) are shaded gray. 
Asterisks indicate identical amino acid residues. 
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The theoretical molecular mass for the putative recombinant mature protein of L. adelaida is 
31.545 kDa, with a pI = 8.85. Expression of L. adelaida SMase D resulted in an approximately 
36 kDa recombinant His6-tagged protein, clearly visible by SDS-PAGE in the bacterial cell 
extracts (Figure 2A). The recombinant protein was purified from the soluble fraction of cell 
lysates by Ni+2-chelating chromatography and eluted from the resin in extraction buffer 
containing 0.8 M imidazole at greater than 95% purity (Figure 2B). 
 
 
 
 
 
 
 
 
 
A 
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Fig. 2. Expression and purification of recombinant SMase D A1 of L. adelaida. [A] Extracts 
of E. coli BL21(DE3) transformed with the plasmid pRSET B clone A1 were induced or 
not with IPTG for 2 h. The cells were collected by centrifugation, resuspended in buffer 
extraction and disrupted by French-pressure. [B] The supernatant was loaded onto 
Ni(II)-Chelating Sepharose column, the flowthrough was collected (FT), the column was 
washed (W1 – W4), and the recombinant protein was eluted with the elution buffer. 
Samples were separated by SDS-PAGE (12% gel) under reducing conditions and stained 
by silver.  
3.2 Enzymatic activity 
The ability of the L. adelaida recombinant SMase D protein to degrade sphingomyelin was 
investigated and compared with the activity of the previously characterized active 
recombinant isoform from L. intermedia gland, SMase D P1, and with L. adelaida crude 
venom. Figure 3 shows that the crude L. adelaida venom, as well as the recombinant  
L. adelaida SMase D A1 and Smase D P1 proteins present significant sphingomyelinase 
activity as shown by the breakdown of the substrate, being the activity of L. adelaida SMase 
D protein lower than that of the L. intermedia SMase P1. However, L. adelaida recombinant 
SMase D activity was approximately ten times higher than that of the crude L. adelaida 
venom. Since the recombinant L. adelaida protein was endowed with sphingomyelinase 
activity, we named it as SMase D A1. 
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Fig. 3. Sphingomyelinase activity of L. adelaida SMase D recombinant protein. 
Sphingomyelin (50 Ǎg) was incubated with increasing amounts of buffer, L. adelaida  or L. 
intermedia recombinant SMases D or crude L. adelaida venom. After 30 min at 37oC, the 
formed choline was oxidized to betaine and determined fluorimetricaly. Results are 
representative for two separate experiments expressed as mean of duplicates +/-SD.  
3.3 Cross-reactivities of SMase D A1 of L. adelaida 
The protein profile from the Loxosceles spp venoms and the recombinant SMases D were 
analyzed by SDS-PAGE followed by silver staining. Figure 4A shows that the venoms from 
L. intermedia, L. laeta, L. gaucho and L. adelaida differ in composition, number and intensity of 
bands. It can also be observed that the recombinant proteins were purified to homogeneity 
and that P1 and A1 exhibit similar molecular weight. SMase I presents Mr of approximately 
33 kDa, and SMases P1 and A1, around 37 kDa and 36 kDa, respectively.  
In order to analyze the inter- and intra-species cross-reactivities, horse polyclonal antiserum 
raised against a combination of the SMases D P1 and P2 from L. intermedia and Smase D I 
from L. laeta, were used in western blotting reactions. Figure 4B shows that the antiserum 
was able to recognize the purified recombinant proteins, SMases D A1, I and P1, as well as 
bands of approximately 35 kDa in the Loxosceles spp spider venoms. The slightly higher Mr 
of the recombinant proteins is attributed to the extra N-terminal tag, which increased the 
size of L. adelaida SMase A1, L. intermedia SMase P1 and L. Laeta  SMase I proteins by, 
approximately, 4 kDa, 3 kDa and 1 kDa, respectively. 
3.4 L. adelaida recombinant SMase D induces haemolysis and dermonecrosis 
Sphingomyelinases D isolated from Loxosceles spider venoms have been shown to be able to 
transform human erythrocytes in activators of the complement system (Tambourgi et al., 
1995, 1998, 2000). In order to assess whether the recombinant SMase A1 could also induce 
Complement-dependent haemolysis, erythrocytes were incubated with increasing amounts 
of the SMases A1, P1 or crude venom. Although the activity of SMase A1 was relatively 
lower compared with the SMase P1 and L. adelaida venom, as shown in Figure 5, L. adelaida 
recombinant SMase A1, as well as SMase P1 and L. adelaida venom were able to render 
erythrocytes susceptible to lysis by autologous Complement. 
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B 
Fig. 4. SDS–PAGE and Western blotting analysis of the recombinant mature L. adelaida 
SMase D protein. Purified recombinant proteins, L. intermedia SMase D P1, L. laeta  
SMase D I and L. adelaida SMase D A1, and L. intermedia, L. laeta, L. gaucho and L. adelaida 
venoms were compared. [A] Samples were separated by SDS-PAGE (12% gel) under non-
reducing conditions and silver stained. [B] Purified recombinant proteins and venoms were 
run on 12% SDS-PAGE gel under non-reducing conditions and western blotted using horse 
antiserum raised against recombinant SMases D P1 and P2 and anti-L. laeta SMase I. 
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Fig. 5. Induction of haemolysis by L. adelaida SMase D A1. Erythrocyte pre-treated with 
different amounts of L. adelaida or L. intermedia recombinant SMases D or crude L. 
adelaida venom or VBS2+ were incubated with NHS. After incubation for 1h at 37oC, the 
absorbance of the supernatant was measured at 414 nm and expressed as percentage of 
lysis. Results are representative for three separate experiments and expressed as mean of 
duplicates +/-SD. 
The ability of L. adelaida recombinant SMase A1 to induce dermonecrotic lesions was tested 
by injecting rabbits with 5 µg of the toxin. The animals received buffer, as negative control, 
and 5 µg of SMase D P1 or venom as positive controls. A typical loxoscelic lesion, as 
revealed by the presence of oedema, oerythema and mild tenderness, developed in the skin 
area injected with the recombinant proteins or venom within a few hours of injection and 
approximately 24 h post injection, necrosis with gravitational spread and scar were 
observed at the inoculation site (Figure 6A). Figure 6B shows that the dermonecrotic action 
of L. adelaida SMase D A1 is dose dependent, but that this activity was less intense than that 
exhibited by the crude venom and SMase D P1.  
Histological analysis of the skin samples obtained from PBS inoculated animals showed a 
thin epidermis and a normal pattern for the collagenous area and muscle fibers (Figure 7, 
panels A/A1/A2). Despite the L. adelaida recombinant SMase D A1 has exhibited lower 
dermonecrotic activity than the Smase D P1, skin samples obtained from the recombinant 
proteins or venom inoculation sites showed a thin epidermis, dissociation of the collagenous 
fibers due to the oedema, degeneration of muscle fibers, moderate haemorrhage in the 
superficial dermis and intense neutrophil infiltration in the deep dermis and musculature 
(Figure 7). 
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Fig. 6. Induction of dermonecrosis by L. adelaida SMase D recombinant protein. [A] Adult 
rabbits were injected intradermally with 5 µg of L. adelaida or L. intermedia recombinant 
SMases D or crude L. adelaida venom. The animals received buffer for negative control 
reactions. The areas of the dermonecrotic lesions were determined 16, 24, 48 and 72 h after 
injection. Results are representative for three separate experiments and expressed as mean 
of duplicates +/-SD. [B] Samples of 5 µg or 10 µg of SMase D A1 were injected intradermally 
in rabbits and the areas of the dermonecrotic lesions were determined 16, 24, 48 and 72 h 
after injection.  
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Fig. 7. Histological analysis. Analysis of skin of rabbits injected with 5 µg L. adelaida or L. 
intermedia recombinant SMases D or crude L. adelaida venom. Control sites were injected 
with an equal volume of phosphate-buffered saline (PBS). Panels correspond to the 
panoramic view of skin sections from rabbits injected with PBS [A], L. adelaida venom [B], 
purified L. adelaida SMase D A1 [C] and L. intermedia SMase D P1 [D]. Arrows indicate areas 
of leukocyte infiltration. Panels A1/2–D1/2 show details of the collagenous area of the 
dermis of the same sections. Bars at the top of each panel indicate 100 µm. 
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3.5 Overall structure description 
MD analysis of L. adelaida SMase D A1 in silico model converged to a RMSD of 1.17 Ǻ and 
showed a stable behavior over the simulation. Global and local stereochemical assessment 
indicated a very good model for comparative structural analyses. SMase D A1 displays a 
typical TIM (ǂ/ǃ)8-barrel fold and its active-site cleft, formed by the metal-binding site (Asp, 
Glu and Asp) and the two catalytic histidines, is furthermore surrounded by the catalytic 
loop (residues 46-60), variable loop (residues 167-175), flexible loop (residues 196-203) and 
other short hydrophobic loops (Figure 8). Based on the current classification of SMases D 
(Murakami et al., 2006), SMase A1 belongs to class II containing an additional disulphide 
bridge (Cys53–Cys201), which connects the catalytic loop to flexible loop (Figure 8). This 
feature, not present in class I SMases D, diminishes significantly the active-site volume and 
also alters the inherent flexibility exhibited by the flexible loop. Beyond that, all the 
structural features observed in class I SMases D are fully conserved and details concerning 
the action mechanism are well described in Murakami et al., 2005 and Murakami et al., 2006.  
 
 
Fig. 8. Structure superposition of Smase D I (class I) and L. adelaida SMase D A1 (class II). 
The residues involved in metal-ion binding and catalysis are presented in atom colors (PDB 
code: 1XX1). Differences in the catalytic, flexible, and variable loops in L. laeta SMase D I 
(blue) and L. adelaida SMase D A1 (green).  
www.intechopen.com
Molecular Cloning, Expression, Function, Structure and Immunoreactivities of  
a Sphingomyelinase D from Loxosceles adelaida, a Brazilian Brown Spider from Karstic Areas 
 
213 
3.6 Sphingomyelin-binding mode to SMases D 
Despite the structure of a SMase D member has been solved, there is neither structural nor 
biophysical data relating the binding mode of the sphingomyelinase (SM) into the active-site 
cleft of SMases D. Thus, in order to shed light into the structural determinants for 
recognition and binding of SM by SMases D, a MD simulation was performed using the 
crystal structure of the SMase D I and the SM docked into enzyme taking into account the 
crystallographic position of the sulphate ion, which provides a good notion how the 
phosphate group from SM is oriented in the active-site cavity. As observed in Figure 9, the 
RMSD of the protein is low (~ 1.5 Å), whereas the SM shows a higher variation in the first 
3000 ps (~ 5.15 Å) and after that become more stable (~ 3 Å). Although, the aliphatic tails of 
the substrate exhibit high flexibility as observed by RMSD analysis over the simulation, the 
polar head is stable. The binding analysis showed that the substrate-enzyme interaction 
increases during the simulation and it stabilizes around 291 Kcal/mol (Figure 9). In 10 ns of 
MD simulation, the model achieved a stable conformation with some fluctuations in the 
aliphatic tails as expected (Figure 9). The choline head is buried in the active-site cleft 
making van der Waals contacts with Trp230, which is conserved among SMases D (Figures 
10A-B). The phosphate moiety is coordinated by the magnesium ion as expected, forming a 
tetrahedral cage of the ion along with the three acidic residues (Figure 10B). The residue 
Lys93, which is also highly conserved, is found in a distance range that permits to interact 
with the carbonyl oxygen of the sphingosine backbone. Val89, Ser132, Asp164, Ser166, 
Pro134, Pro168, Tyr169, Leu170, Leu198, Tyr228 and Met250 are also participating in the 
coordination of the substrate (Figure 10B). These data corroborates with previous 
crystallographic studies, whose suggested the importance of Lys93, Trp230 and other 
aromatic residues in the recognition and interaction of the substrate. 
 
 
Fig. 9. MD simulation of SM/SMase D I complex. [A] RMSD of the protein (light gray) and 
the substrate (dark gray). MD structural frames in 0 ns (initial state) [B], 10 ns [C] and 20 ns 
(final state) [D]. 
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Fig. 10. Binding mode of sphingomyelin in SMase D I. [A] Surface representation of the 
active-site cavity with the substrate. [B] Schematic representation of the residues involved in 
the sphingomyelin (SM) interaction.  
4. Discussion 
Previously, we have characterized the biochemical and biological properties of L. adelaida 
venom and evaluate the toxic potential of envenomation by this non-synanthropic Loxosceles 
species (Pretel et al., 2005). The biological activities of the L. adelaida venom was compared to 
that of Loxosceles gaucho, a synanthropic species of medical importance in Brazil. L. adelaida 
venom showed a similar potential to induce haemolysis, dermonecrosis and lethality as L. 
gaucho venom. Thus, showing that the troglophile Loxosceles species, L. adelaida, commonly 
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found in the complex of caves from PETAR, is potentially able to cause envenomation with 
the same gravity of those produced by synanthropic species. 
Since various studies have indicated that sphingomyelinase D  present in the venoms of 
Loxosceles spiders is the main component responsible for the local and systemic effects 
observed in loxoscelism, we have cloned and expressed a SMase D from the spider gland of 
L. adelaida to compare the functional activities of the recombinant protein with toxins from 
synanthropic species and to investigate the inter- and intra-species cross-reactivities of 
antibodies raised against the purified recombinant proteins.  
The L. adelaida SMase D A1 cDNA exhibits similarity with previously characterized class 2 
SMase D, i.e., the SMase P1 from L. intermedia. Both sequences show the residues of the 
active site pocket, i.e, His12, Glu32, Asp34, Asp91, His47, Asp52, Trp230, Asp233, and Asn252, which 
are essential for the metal-ion binding of SMases D (Mg2+ is coordinated by Glu32, Asp34, 
Asp91), and for acid-base catalytic mechanisms (His12 and His47 play key roles and are 
supported by a network of hydrogen bonds between Asp34, Asp52, Trp230, Asp233, and 
Asn252) (Murakami et al., 2005,  and Figures 1, 8 and 10).  The importance of histidine 
residues was also demonstrated by Lee et al. (2005) through site-directed mutagenesis of a 
Loxosceles reclusa recombinant SMase D isoform. 
Antiserum produced against the recombinant SMases D P1, P2, from L. intermedia, and I, 
from L. laeta was highly cross-reactive against L. adelaida SMase A1, and also exhibit a high 
level of recognition to SMases present in Loxosceles adelaida and L. gaucho venoms. These data 
suggest that SMases D from Loxosceles species analized share the main immunogenic 
epitopes. This also means that this antivenom is of potential benefit to patients being bitten, 
not only by the spiders of the Loxosceles species, which the antiserum was raised against, but 
also by L. adelaida. 
We show here that the SMases D A1 and P1 in spite of their cross-reactivity, being able to 
induce a typical dermonecrotic reaction, exhibit differences in their toxic potential, being the 
lesions produced by L. adelaida SMase A1 smaller than that induced by SMase P1. These 
enzymes were also able to transform erythrocytes into activators of the autologous 
complement system, as demonstrated by increase of lysis susceptibility in the presence of 
complement. But, again, SMase D P1 was more active than A1. 
Based on sequence and structural similarities, the SMases D can be grouped into two classes 
depending on the presence of an additional disulphide bridge between the catalytic loop 
and flexible (Murakami et al., 2006). L. adelaida SMase D A1 is a class II member and 
conserves all structural features for catalytic activity upon sphingomyelin. MD simulations 
indicated the binding mode of SM in the SMase I, a class I member that already has its 
crystallographic structure solved (Murakami et al., 2005) and they demonstrated the role 
exerted by Trp230 in the orientation of choline head, the magnesium ion in the coordination 
of the phosphate group and other aliphatic residues in the stabilization of substrate at the 
active site. 
In conclusion, we have cloned, expressed and biochemically and structurally characterized a 
new sphingomyelinase D from Loxosceles adelaida spider and shown that it displays all the 
functional characteristics of whole venom. The recombinants toxins, representing different 
classes of SMase D molecules, will allow us to further characterize the functionally 
important domains of these proteins. The identification of the active site(s) would aid in the 
design and testing of suitable anti-sphingomyelinase compounds in the development of 
novel therapies to treat loxoscelism. 
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